Acta Scientific Otolaryngology (ASOL) (ISSN: 2582-5550)

Case Report Volume 7 Issue 7

LMN Facial Palsy After Second Dose of COVID Vaccine: A Case Report

Milan S Babu1, Syeda Shamim Fatima2, Tanuj Madan1*, DVS Mithilesh3, Jijesh Jayadevan3 and RN Harish4

1Assistant Professor, Department of ENT, Military Hospital - Jabalpur, Madhya Pradesh, India
2Assistant Professor, Department of ENT, Military Hospital - Kirkee, Pune, Maharashtra
3Consultant, Department of ENT, 165 Military Hospital - Dimapur, Assam, India
4Junior Resident-I, Department of ENT, Command Hospital- Kolkata, Alipore, Kolkata, West Bengal, India

*Corresponding Author: Tanuj Madan, Assistant Professor, Department of ENT, Military Hospital - Jabalpur, Madhya Pradesh, India.

Received: June 04, 2025; Published: June 20, 2025

Abstract

COVID-19 was declared a pandemic by WHO during April 2020. Large scale spread of disease necessitated the development of novel COVID-19 vaccines. Few cases of LMN facial palsies were reported during its clinical trial as well as during its use in general population. A case of LMN Facial palsy in a 22 year old male patient managed at our centre following second dose of COVID-19 vaccination is being reported here

Keywords: COVID-19; Facial Palsy; Bell’s Palsy; COVID Vaccination

References

  1. World Health Organization. “COVID-19 vaccines: safety surveillance manual”.
  2. US Food and Drug Administration. “Pfizer-BioNTech COVID-19 vaccine emergency use authorization review memorandum” (2020).
  3. US Food and Drug Administration. “Moderna COVID-19 vaccine emergency use authorization review memorandum” (2020).
  4. Mazur M., et al. “Facial and Oral Manifestations Following COVID-19 Vaccination: A Survey-Based Study and a First Perspective”. International Journal of Environmental Research and Public Health9 (2021): 4965.

Citation

Citation: Milan., et al. “LMN Facial Palsy After Second Dose of COVID Vaccine: A Case Report".Acta Scientific Otolaryngology 7.7 (2025): 32-34.

Copyright

Copyright: © 2025 Tanuj Madan., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate34%
Acceptance to publication20-30 days
Impact Factor0.871

Indexed In







News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.

Contact US